Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 AUD | +4.56% | -3.23% | +20.00% |
Mar. 18 | Regis Healthcare Limited(ASX:REG) added to S&P/ASX Small Ordinaries Index | CI |
Mar. 18 | Regis Healthcare Limited(ASX:REG) added to S&P/ASX 300 Index | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company has insufficient levels of profitability.
- The company is highly valued given the cash flows generated by its activity.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.00% | 735M | B- | ||
-18.46% | 16.57B | B+ | ||
+4.50% | 12.38B | B | ||
+4.98% | 11.73B | B+ | ||
+5.10% | 10.27B | B+ | ||
+25.03% | 8.4B | B | ||
-2.64% | 7.63B | A- | ||
+20.21% | 7.16B | D | ||
+3.87% | 6.63B | B- | ||
+50.68% | 4.58B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- REG Stock
- Ratings Regis Healthcare Limited